Usha Chakravarthy

Professor, Institute for Ophthalmology and Vision Science, Queen’s University, Belfast

A particularly prominent retinal surgeon, Usha Chakravarthy has been involved in many of the major international clinical trials with therapeutics, including the IVAN, INTREPID, EUREYE, INDEYE, and VISION studies, as well as being a co-author of multiple Cochrane Review articles, plus the Royal College of Ophthalmologists guidelines for the treatment of AMD. She continues to work at the forefront of AMD research, investigating issues such as the long-term effectiveness of anti-VEGF regimens, and the factors that affect patients’ response to anti-VEGF therapy.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016